08/09/2017

NCCN has published updates to the NCCN Guidelines® and the NCCN Compendium® for Esophageal and Esophagogastric Cancer

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) and the NCCN Drugs & Biologics Compendium (NCCN Compendium^®) for Esophageal and Esophagogastric Cancer. These NCCN Guidelines^® are currently available as Version 2.2017. 

• Workup (ESOPH-1)
  • Recommendation was revised: “Endoscopic ultrasound (EUS), if no evidence of M1 unresectable disease”.
• Squamous cell carcinoma and Adenocarcinoma
  • Additional Evaluation (as clinically indicated) (ESOPH-2 and ESOPH-11)
• Recommendation was revised: “Consider nasogastric or J tube (preferred) enteric feeding tube (jejunostomy tube preferred) or PEG tube for preoperative nutritional support.”
• Principles of Surveillance (ESOPH-I)
  • The recommendations in this section were extensively revised.

*For your reference, the previous update (Version 1.2017) to the NCCN Guidelines for Esophageal and Esophagogastric Cancer, published on March 21, 2017, is available at the following link: https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf.